Manufacturing, Gene Therapies

Eurofins Genomics Acquires Blue Heron Biotech, Expands Gene Synthesis Capabilities

August 12, 2019

The acquisition expands Eurofins Genomics’ gene portfolio while bolstering Blue Heron’s production capabilities.

Abcam Acquires EdiGene’s Entire Live Cell Lines and Lysates Portfolio

July 17, 2019

Abcam has acquired the entire live cell line and lysates portfolio of gene-editing therapy developer, EdiGene.

Amicus Partners with Catalent on Lysosomal Disease Gene Therapy Programs

July 03, 2019

Metabolic-disease biotech Amicus Therapeutics announced a manufacturing agreement with Catalent’s Paragon Gene Therapy unit for gene therapy manufacturing.

Source of Nucleic-Acid Asymmetry May Advance Gene Therapy

July 01, 2019

Pharmaceutical Technology's In the Lab eNewsletter

Research from the Institute for Research in Biomedicine offers insight into the source of asymmetry between nucleic acid hybrids.

Partnership Forms to Standardize Cell and Gene Therapy Supply Chain Solutions

June 19, 2019

Be The Match BioTherapies and TrakCel have announced a collaboration to provide integrated solutions for companies developing cell and gene therapies.

Locate Bio Receives Investment to Expand its Cell and Gene Therapy Pipeline

May 16, 2019

Locate Bio has been granted additional investment to the tune of £2 million (US$2.6 million) for the expansion of its cell and gene therapy pipeline.

Freeline Installs Pall System at Gene Therapy Facility

May 03, 2019

In collaboration with Pall Corportion, biotech company Freeline completed the first full-scale run at its newly commissioned, GMP gene-therapy manufacturing facility in the UK.

NJII and Pall Partner on Cell and Gene Therapy Manufacturing Development

March 29, 2019

NJII and Pall collaborate to address biomanufacturing technology and workforce development challenges.

MaSTherCell Announces New Commercial Manufacturing Facility for Cell and Gene Therapies

March 26, 2019

Belgium-based CDMO MaSTherCell will expand its European manufacturing capacity for cell and gene therapy products by setting up a new facility in Belgium.

The Link Between Manufacturing and Commercialization in Gene and Cell Therapy

March 20, 2019

Equipment and Processing Report

Think ahead to production requirements when planning strategies in early development of gene and cell therapies.